Annual Accounts Payable
$5.05 M
+$4.14 M+458.41%
December 31, 2023
Summary
- As of February 8, 2025, ACRV annual accounts payable is $5.05 million, with the most recent change of +$4.14 million (+458.41%) on December 31, 2023.
- During the last 3 years, ACRV annual accounts payable has risen by +$4.91 million (+3611.76%).
- ACRV annual accounts payable is now at all-time high.
Performance
ACRV Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.51 M
+$245.00 K+19.43%
September 30, 2024
Summary
- As of February 8, 2025, ACRV quarterly accounts payable is $1.51 million, with the most recent change of +$245.00 thousand (+19.43%) on September 30, 2024.
- Over the past year, ACRV quarterly accounts payable has increased by +$2000.00 (+0.13%).
- ACRV quarterly accounts payable is now -70.17% below its all-time high of $5.05 million, reached on December 31, 2023.
Performance
ACRV Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ACRV Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +458.4% | +0.1% |
| 3 y3 years | +3611.8% | +0.1% |
| 5 y5 years | +3611.8% | +0.1% |
ACRV Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +458.4% | -70.2% | +66.6% |
| 5 y | 5-year | at high | +3611.8% | -70.2% | +66.6% |
| alltime | all time | at high | +3611.8% | -70.2% | +66.6% |
Acrivon Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.51 M(+19.4%) |
| Jun 2024 | - | $1.26 M(-38.7%) |
| Mar 2024 | - | $2.06 M(-59.3%) |
| Dec 2023 | $5.05 M | $5.05 M(+235.6%) |
| Sep 2023 | - | $1.50 M(+18.7%) |
| Jun 2023 | - | $1.27 M(-7.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $1.37 M(+52.0%) |
| Dec 2022 | $904.00 K(-6.2%) | $904.00 K(-54.3%) |
| Sep 2022 | - | $1.98 M(+3.9%) |
| Jun 2022 | - | $1.90 M(+97.3%) |
| Dec 2021 | $964.00 K(+608.8%) | - |
| Dec 2021 | - | $964.00 K |
| Dec 2020 | $136.00 K | - |
FAQ
- What is Acrivon Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Acrivon Therapeutics?
- What is Acrivon Therapeutics annual accounts payable year-on-year change?
- What is Acrivon Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Acrivon Therapeutics?
- What is Acrivon Therapeutics quarterly accounts payable year-on-year change?
What is Acrivon Therapeutics annual accounts payable?
The current annual accounts payable of ACRV is $5.05 M
What is the all time high annual accounts payable for Acrivon Therapeutics?
Acrivon Therapeutics all-time high annual accounts payable is $5.05 M
What is Acrivon Therapeutics annual accounts payable year-on-year change?
Over the past year, ACRV annual accounts payable has changed by +$4.14 M (+458.41%)
What is Acrivon Therapeutics quarterly accounts payable?
The current quarterly accounts payable of ACRV is $1.51 M
What is the all time high quarterly accounts payable for Acrivon Therapeutics?
Acrivon Therapeutics all-time high quarterly accounts payable is $5.05 M
What is Acrivon Therapeutics quarterly accounts payable year-on-year change?
Over the past year, ACRV quarterly accounts payable has changed by +$2000.00 (+0.13%)